MSI-H
Clinical trials for MSI-H explained in plain language.
Never miss a new study
Get alerted when new MSI-H trials appear
Sign up with your email to follow new studies for MSI-H, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can immunotherapy outperform chemo after stomach cancer surgery?
Disease control OngoingThis trial is testing whether giving a PD-1 immunotherapy drug after surgery can help people with a specific type of stomach cancer (MSI-H) live longer without the cancer coming back. Participants who had surgery to remove their stomach cancer will be randomly assigned to receive…
Matched conditions: MSI-H
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug duo shows promise against aggressive colon cancer
Disease control OngoingThis study tests whether giving two immunotherapy drugs (IBI310 and sintilimab) before surgery can eliminate or shrink tumors in people with a specific genetic type of colon cancer (MSI-H/dMMR). About 453 adults with stage IIB or III colon cancer that can be surgically removed wi…
Matched conditions: MSI-H
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC